Plasma protein fraction
Plasma protein fraction is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| signs and symptoms pathological conditions | D013568 |
Trade Name
FDA
EMA
Plasmanate
Drug Products
FDA
EMA
Reference product - 351(a)
Reference product - 351(a)
Interchangeable product - 351(k)
Interchangeable product - 351(k)
Biosimilar product - 351(k)
Biosimilar product - 351(k)
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| plasmanate | Biologic Licensing Application | 2010-04-30 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
Clinical
Clinical Trials
558 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 14 | — | — | 1 | 16 | 31 |
| Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | — | 2 | — | 1 | 18 | 21 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 3 | — | 1 | 11 | 15 |
| Syndrome | D013577 | — | — | 2 | 1 | 2 | 1 | 9 | 14 |
| Sepsis | D018805 | HP_0100806 | A41.9 | — | 1 | 2 | 1 | 10 | 14 |
| Infections | D007239 | EFO_0000544 | — | — | — | — | 3 | 9 | 12 |
| Hemorrhage | D006470 | MP_0001914 | R58 | — | 1 | 2 | 2 | 6 | 11 |
| Inflammation | D007249 | MP_0001845 | — | — | — | 1 | 3 | 7 | 11 |
| Hemophilia a | D006467 | EFO_0007267 | D66 | 1 | — | 4 | 5 | 1 | 11 |
| Leukemia | D007938 | — | C95 | 5 | 5 | — | 1 | 2 | 9 |
Show 57 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Multiple myeloma | D009101 | — | C90.0 | 12 | 14 | 2 | — | 8 | 29 |
| Plasma cell neoplasms | D054219 | — | — | 12 | 13 | 2 | — | 7 | 27 |
| Neoplasms | D009369 | — | C80 | 8 | 2 | 1 | — | 10 | 19 |
| Non-small-cell lung carcinoma | D002289 | — | — | 1 | 9 | 1 | — | 7 | 18 |
| Lung neoplasms | D008175 | HP_0100526 | C34.90 | 2 | 5 | 2 | — | 8 | 17 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 8 | 1 | — | 4 | 13 |
| Covid-19 | D000086382 | — | — | 2 | 2 | 4 | — | 6 | 12 |
| Paraproteinemias | D010265 | — | D47.2 | — | 3 | 2 | — | 6 | 11 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | 1 | — | 9 | 10 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | 1 | 3 | 2 | — | 2 | 7 |
Show 38 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | 1 | — | — | 12 | 13 |
| Lymphoma | D008223 | — | C85.9 | 5 | 5 | — | — | 4 | 11 |
| Monoclonal gammopathy of undetermined significance | D008998 | EFO_1000836 | D47.2 | — | 4 | — | — | 6 | 10 |
| Carcinoma | D002277 | — | C80.0 | — | 1 | — | — | 8 | 9 |
| Cardiovascular diseases | D002318 | HP_0001626 | — | — | 1 | — | — | 7 | 8 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | 1 | — | — | 5 | 7 |
| Insulin resistance | D007333 | HP_0000855 | — | — | 1 | — | — | 6 | 7 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | 2 | 2 | — | — | 2 | 6 |
| Smoldering multiple myeloma | D000075122 | — | — | 1 | 4 | — | — | 1 | 6 |
| Chronic kidney failure | D007676 | EFO_0003884 | N18.9 | — | 1 | — | — | 5 | 6 |
Show 57 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Obesity | D009765 | EFO_0001073 | E66.9 | 3 | — | — | — | 10 | 13 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | 1 | — | — | — | 9 | 10 |
| Renal insufficiency | D051437 | HP_0000083 | N19 | 1 | — | — | — | 5 | 6 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 1 | — | — | — | 4 | 5 |
| Liver diseases | D008107 | HP_0002910 | K70-K77 | 1 | — | — | — | 3 | 4 |
| Rotator cuff injuries | D000070636 | — | M75.1 | 2 | — | — | — | — | 2 |
| Osteonecrosis | D010020 | EFO_0004259 | M87 | 1 | — | — | — | 1 | 2 |
| Glioma | D005910 | EFO_0000520 | — | 1 | — | — | — | 1 | 2 |
| Severe acute respiratory syndrome-related coronavirus | D045473 | NCBITaxon_227859 | — | 2 | — | — | — | — | 2 |
| Cysts | D003560 | — | — | 1 | — | — | — | 1 | 2 |
Show 27 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chronic renal insufficiency | D051436 | — | N18 | — | — | — | — | 5 | 5 |
| Metabolic diseases | D008659 | EFO_0000589 | E88.9 | — | — | — | — | 5 | 5 |
| Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | — | — | — | 5 | 5 |
| Colorectal neoplasms | D015179 | — | — | — | — | — | — | 4 | 4 |
| Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | — | — | — | 4 | 4 |
| Renal dialysis | D006435 | EFO_0010690 | Z99.2 | — | — | — | — | 4 | 4 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | — | — | — | — | 4 | 4 |
| Cardiomyopathies | D009202 | EFO_0000318 | I42 | — | — | — | — | 4 | 4 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | — | — | — | 4 | 4 |
| Dementia | D003704 | EFO_0003862 | F03 | — | — | — | — | 4 | 4 |
Show 367 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Plasma protein fraction |
| INN | — |
| Description | Plasma protein fraction is an unknown pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Protein |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL2108773 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 55,172 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
38 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use